Pyxis Oncology CEO Lara Sullivan's 2021 pay jumps 3,011% to $17M
Pyxis Oncology reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Pyxis Oncology reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, three executives at Pyxis Oncology received on average a compensation package of $9.2M, a 1,564% increase compared to previous year.
Average pay of disclosed executives at Pyxis Oncology
Lara Sullivan, Chief Executive Officer, received $17M in total, which increased by 3,011% compared to 2020. 95% of Sullivan's compensation, or $16M, was in option awards. Sullivan also received $342K in non-equity incentive plan and $565K in salary.
Jay Feingold, Chief Medical Officer, received a compensation package of $7.7M. 86% of the compensation package, or $6.6M, was in option awards.
Pamela Connealy, Chief Financial Officer, earned $2.7M in 2021.
Related executives
You may also like
Source: SEC filing on April 28, 2022.